Excluded studies with reasons for exclusion. by Si He (3236646)

“…The overall results revealed that NPWT significantly decreased the sternal wound reinfection (SWRI) rate (RR [95% CI] = 0.179 [0.099 to 0.323], 95% prediction interval [PI]: 0.082 to 0.442), in-hospital mortality (RR [95% CI] = 0.242 [0.149 to 0.394], 95% PI: 0.144 to 0.461), and shortened the length of intensive care unit (ICU) stay (SMD [95% CI] = −0.601 [−0.820 to −0.382], 95% PI: −1.317 to 0.128) compared with conventional wound care. …”

Study areas of sample collection in Ethiopia, eastern Africa by Amete Mihret Teshale (12072758)

PeMSD8. by Yuanming Ding (12842858)

Forest plots of primary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Forest plots of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Positive stool samples by pathogen and study sites. by Amete Mihret Teshale (12072758)

Socio-demographic and clinical characteristics of participants by study site. by Amete Mihret Teshale (12072758)

Odds Ratio of multivariable analysis of factors for <i>Campylobacter species.</i> by Amete Mihret Teshale (12072758)

Odds ratio of multivariable analysis of factors for non-typhoidal <i>Salmonella.</i> by Amete Mihret Teshale (12072758)

Trial sequential analysis of primary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Trial sequential analysis of secondary outcomes after negative pressure wound therapy versus conventional wound care for sternal wound infection. by Si He (3236646)

Mean age of patients submitting stool samples per study site. by Amete Mihret Teshale (12072758)

Odds ratio of multivariable analysis of factors for Shiga toxin-producing <i>Escherichia coli</i> (<i>stx</i> only). by Amete Mihret Teshale (12072758)

Odds ratio of multivariable analysis of factors for Shiga-toxin producing <i>Escherichia coli</i> (<i>stx</i> by Amete Mihret Teshale (12072758)

Two-dimensional quadrant analysis of cherry shrimp (<i>N</i>. <i>davidi</i> var. red) bodycolor parameters (<i>L*</i> and <i>a*</i> values) in different feed treatment groups on da... by Wei-Wei Hou (3405947)

Calibration of standards. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Appearance of standards under UV 365 nm. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

HPLC-Chromatogram of methanol fraction. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on kidney profile test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”

Effects of <i>B</i>.<i>erecta</i> on Morris water maze test. by Asif Khan (1740271)

“…<i>erecta</i> may be a promising medicinal agent for reducing the risk and progression of Parkinson’s disease.…”